Skip to content

Clinical trials

Lymphoma, T-Cell, Peripheral trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, T-Cell, Peripheral Country / region: Taiwan Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20162
20181
20212
20221
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Active, not recruiting2
Recruiting2
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Acrotech Biopharma Inc.1
AstraZeneca1
BeiGene1
Daiichi Sankyo1
Dizal Pharmaceuticals1
Great Novel Therapeutics Biotech & Medicals Corporation1
National Health Research Institutes, Taiwan1
Solasia Pharma K.K.1
Taiwan Mundipharma Pharmaceuticals Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, T-Cell, Peripheral9
Recurrence3
Disease Progression1
Immunoblastic Lymphadenopathy1
Lymphoma, Extranodal NK-T-Cell1
Lymphoma, Large-Cell, Anaplastic1
Lymphoma, T-Cell1
Lymphoma, T-Cell, Cutaneous1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.